Table 3.
Low-pTau | High-pTau | Low-pTau versus High-pTau | |||||||||||||
Baseline (B) | 1 year after (1 y) | 2 years after (2 y) | p-value | Baseline (B) | 1 year after (1 y) | 2 years after (2 y) | p-value | p-value | |||||||
B versus 1 y | B versus 2 y | 1 versus 2 y | B versus 1 y | B versus 2 y | 1 versus 2 y | B | 1y | 2y | |||||||
Neuropsychological test: median [min-max] | |||||||||||||||
MMSE | 23 [15–29] | 26 [18–29] | 25 [17–30] | **0.001 | 0.079 | 0.104 | 22 [16–28] | 24 [10–27] | 20 [0–22] | 0.893 | **0.007 | **0.005 | 0.698 | 0.052 | **0.001 |
FAB | 11.5 [4–17] | 12 [7–18] | 12.5 [6–17] | **0.005 | *0.039 | 0.284 | 9 [4–15] | 11 [3–16] | 11 [3–15] | 0.944 | 0.943 | 0.783 | 0.404 | 0.139 | 0.247 |
Clinical findings: median [min-max] | |||||||||||||||
mRS | 3 [1–4] | 3 [1–4] | 2 [1–4] | *0.017 | **0.001 | 0.285 | 3 [2–4] | 2 [1–4] | 3 [1–4] | 0.157 | 0.608 | *0.038 | 0.555 | 0.445 | 0.063 |
INPHGS | |||||||||||||||
Gait disturbance | 2 [1–4] | 2 [0–3] | 2 [0–3] | ***<0.001 | ***<0.001 | 0.166 | 2 [2–3] | 2 [1–4] | 3 [1–4] | 0.480 | 0.739 | 0.083 | 0.655 | 0.879 | 0.163 |
Dementia | 2 [0–3] | 1 [0–3] | 1 [0–3] | **0.005 | **0.003 | 1.000 | 2 [1–3] | 2 [1–4] | 3 [1–4] | 0.414 | 0.305 | 0.058 | 0.608 | 0.219 | **0.006 |
Urinary incontinence | 2 [0–3] | 1 [0–3] | 1 [0–3] | ** 0.001 | **0.003 | 0.193 | 2 [1–3] | 1 [1–4] | 2 [1–4] | 0.550 | 0.319 | *0.023 | 0.937 | 0.496 | **0.002 |
Biomarkers: mean ± SD | Baseline (B) | 1 year after (1 y) | 1 y/B | B versus 1 y | Baseline (B) | 1 year after (1 y) | 1 y/B | B versus 1 y | Low- versus High-pTau (B) | Low- versus High-pTau (B) | |||||
pTau (pg/ml) | 20.1 ± 4.7 | 55.0 ± 29.7 | 2.73 | ***<0.001 | 39.4 ± 8.9 | 93.6 ± 53.2 | 2.38 | *0.019 | ***<0.001 | *0.037 | |||||
Aβ42 (pg/ml) | 487.1 ± 227.6 | 786.2 ± 265.7 | 1.61 | ***<0.001 | 496.8 ± 300.3 | 507.6 ± 348.6 | 1.02 | 0.534 | 0.735 | *0.014 | |||||
Aβ42 toxic conformer (pg/ml) | 53.4 ± 18.2 | 69.7 ± 17.0 | 1.31 | ***<0.001 | 62.3 ± 18.4 | 66.6 ± 26.4 | 1.12 | 0.423 | 0.203 | 0.252 | |||||
Aβ42 toxic conformer ratio (%) | 13.3 ± 9.4 | 10.3 ± 5.5 | 0.77 | 0.116 | 15.2 ± 7.3 | 15.7 ± 6.1 | 1.03 | 0.107 | 0.770 | **0.002 |
Results are shown as the median [minimum-maximum] or mean ± SD. Mann-Whitney U tests were used to compare low-pTau versus high-pTau groups and Wilcoxon signed-rank tests were used for all other comparisons. *p < 0.05, **p < 0.01, and ***p < 0.001 were considered to be statistically significant. MMSE, Mini-Mental State Examination; FAB, frontal assessment battery; mRS, modified Rankin scale; INPHGS, iNPH grading scale.